# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-26-056595
Filing Date
2026-05-14
Accepted
2026-05-14 16:05:36
Documents
75
Period of Report
2026-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | QUARTERLY REPORT | ea0289477-10q_jasper.htm iXBRL | 10-Q | 770482
2 | CERTIFICATION | ea028947701ex31-1.htm | EX-31.1 | 11226
3 | CERTIFICATION | ea028947701ex31-2.htm | EX-31.2 | 11100
4 | CERTIFICATION | ea028947701ex32-1.htm | EX-32.1 | 7351
| Complete submission text file | 0001213900-26-056595.txt |  | 5019343

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
5 | XBRL SCHEMA FILE | jspr-20260331.xsd | EX-101.SCH | 55047
6 | XBRL CALCULATION FILE | jspr-20260331_cal.xml | EX-101.CAL | 33143
7 | XBRL DEFINITION FILE | jspr-20260331_def.xml | EX-101.DEF | 182754
8 | XBRL LABEL FILE | jspr-20260331_lab.xml | EX-101.LAB | 379143
9 | XBRL PRESENTATION FILE | jspr-20260331_pre.xml | EX-101.PRE | 303982
79 | EXTRACTED XBRL INSTANCE DOCUMENT | ea0289477-10q_jasper_htm.xml | XML | 556197

Mailing Address 2200 BRIDGE PKWY SUITE #102 REDWOOD CITY CA 94065
Business Address 2200 BRIDGE PKWY SUITE #102 REDWOOD CITY CA 94065 6505491400
Jasper Therapeutics, Inc. (Filer) CIK: 0001788028 (see all company filings)

EIN.: 842984849 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39138 | Film No.: 26978754
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)